Summary
In calcium lithiasis, inhibitors have a significant effect in reducing the crystallization process. This work evaluated orthophosphate in a group of patients with calcium oxalate lithaisis, and in a control group. The study of orthophosphate and pyrophosphate, showed differences between stone formers and the control group. These results could be attributed to a failure in the renal transformation of orthophosphate into pyrophosphate.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Baumann JM, Bisaz S, Felix R, Fleisch H, Ganz U, Russell RGG (1977) The role of inhibitors and other factors in the pathogenesis of recurrent calcium-containing renal stones. Clin Sci Mol Med 53:141
Fleisch H, Bisaz S (1964) The inhibitory effect of pyrophosphate on calcium oxalate precipitation and its relation to urolithiasis, Experientia 20:276
Gardner GL, Doremus RH (1978) Crystal grwwth inhibitors in human urine. Effect on calcium oxalate kinetics. Invest Urol 15:178
Genestar C, Salgado J, Coll R, Conte A, Grases F (in press) Simplified method for enzymatic pyrophosphate assay. A comparative study between stone formers and healthy people. Z Urol Nephol
Grases F, Gil JJ, Conte A (1989) Urolithiasis inhibitors and calculus nucleation. Urol Res 17:163–166
Kornberg A (1962) On the metabolic significance of phosphorolytic and pyrophosphorolytic reactions. In: Kasha M, Pullman D (eds) Horizons in biochemistry. Academic Press, New York, p 251
Meyer JL, Smith LH (1975) Growth of calcium oxalate crystals. II. Inhibition by natural urinary crystal growth inhibitors. Invest Urol 13:36
Nancollas GH, Gardner GL (1974) Kinetics of crystal growth of calcium oxalate monohydrate. J Crystal Growth 21:267
Pak CYC, Holt K (1976) Nucleation and growth of brushite and calcium oxalate in urine of stone-formers. Metabolism 25:665
Pak CYC, Galosy RA (1980) Propensity for spontaneous nucleation of calcium oxalate. Am J Med 69:681
Peacock M, Robertson WG, Heyburn PJ, Davies AEJ, Rutherford A (1981) Phosphate treatment of idiopathic calcium stone disease. In: Smith LH, Robertson WG, Finlayson B (eds) Urolithiasis — clinical and basic research. Plenum Press, New York, p 259
Robertson WG, Peacock M, Nordin BEC (1973) Inhibitors of the growth and aggregation of calcium oxalate cyrstals in vitro. Clin Chim Acta 43:31
Russell RGG, Edwards NA, Hodgkinson A (1964) Urinary pyrophosphate and urolithiasis. Lancet I:1446
Russell RGG, Bisaz S, Fleisch H (1976) The influence of orthophosphate on the renal handling of inorganic pyrophosphate in man and dog. Clin Sci Med 51:435
Smith LH, Thomas WC, Arnaud CD (1973) Orthophosphate therapy in calcium renal lithiasis. In: Cifuentes Delate L, Rapado, Hodgkinson A (eds) Urniary calculi. Rarger, Basel, p 188
Werness PG, Duckworth SC, Smith LH (1979) Calcium oxalate dihydrate crystal growth. Invest Urol 17:230
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Conte, A., Roca, P., Genestar, C. et al. The relation between orthophosphate and pyrophosphate in normal subjects and in patients with urolithiasis. Urol. Res. 17, 173–175 (1989). https://doi.org/10.1007/BF00256246
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00256246